Treatment for Clostridium-difficile Infection With IMM529, page-21

Based on a conversation with investor relations I had about six months ago. Immuron is looking to leverage its work with the US military to speed up FDA approval. Because the US military has been investigating the drug and if they want it and give it the tick of approval then the FDA process is likely to be fast tracked. FDA approval also opens the European market automatically so it would be big for Immuron. Since then the results out of the military have been stella around travelan and the military has expanded its work with travelan to the development of a vaccine.
The million dollar question is when/if all this work with the US military will result in more sales of Travelan, FDA approval etc.

An update from management would be good on what is happening and what their plans are. They don't say much in public.